Syndax Pharmaceuticals
SNDX
SNDX
57 hedge funds and large institutions have $79.8M invested in Syndax Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less capital invested
Capital invested by funds: $176M → $79.8M (-$95.9M)
Holders
57
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.43M | |
| 2 | +$1.24M | |
| 3 | +$717K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$699K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$403K |
Top Sellers
| 1 | -$4.41M | |
| 2 | -$2.08M | |
| 3 | -$1.44M | |
| 4 |
GE
General Electric
Evendale,
Ohio
|
-$726K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$599K |